BGM

BGM Group Ltd. Class A Ordinary Shares (BGM)

Stock · NASDAQ · Health Care

$8.65as of 10/16/2026

AI Market Commentary

AI-generatedAll commentary →

Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.

September 28, 2026

BGM Group listed among moving health care stocks. BGM Group was included in recent lists of health care stocks moving in pre- and after-market sessions. The company is currently trading near its 52-week low, with a support level at $0.28. These listings indicate heightened volatility and active trading interest in the stock during recent sessions.

Active signals

Support level
$0.3515
Industry
Biotechnology: Pharmaceutical Preparations

What BGM's price did in the 20 trading sessions after each past signal, compared with any 20-session window over the same period.

SignalTimesMedian 20-session returnHigher after 20 sessions
Volume Spike27-4.0%48%
Bollinger Band Breakout19-8.1%32%
Bollinger Band Breakdown17-4.1%35%
200-Day Moving Average TouchActive now9-2.8%33%
Any 20-session window (baseline)-3.4%40%

Computed by MarketWall from daily closing prices since May 18, 2022. Returns are close-to-close and don't include dividends. Past results describe what happened before; they are not a forecast and not investment advice.

About BGM

BGM Group Ltd., through its subsidiaries, operates as a pharmaceutical and chemical company in China. The company operates through Diversified Pharmaceutical and Allied Products; AI Solution; and Insurance Business segments. It offers oxytetracycline products, including Qilian Shan oxytetracycline tablets to prevent and treat a range of diseases in chickens, turkeys, cattle, swine, and human; and Qilian Shan oxytetra…

Sector
Health Care
Industry
Biotechnology: Pharmaceutical Preparations

Fundamentals

1-day range
$8.65$8.94
Market cap
$118.62M
P/E (trailing)
—
P/E (forward)
—
EPS (trailing)
$-0.13
Dividend yield
—
Beta
1.93
Avg. volume
6.3K
Ex-dividend date
February 27, 2023
Dividend pay date
March 6, 2023
52-week range
$6.45$303
Next earnings: March 16, 2026

BGM Group Ltd. Class A Ordinary Shares Competitors

Chosen by industry and closest market cap.

  • BGM
    BGM Group Ltd. Class A Ordinary Shares
    $8.65
    ▲ 0.70%
    Market cap $118.62MP/E —
    $6.45$303
  • PMN
    ProMIS Neurosciences Inc. Common Shares (ON)
    $8.15
    ▼ 6.32%
    Market cap $119.54MP/E —
    $6.27$27.4
  • YARW
    Yarrow Bioscience Inc. Common Stock
    $18.31
    ▼ 8.45%
    Market cap $116.71MP/E —
    $18.16$44.28
  • ANIX
    Anixa Biosciences Inc. Common Stock
    $2.67
    ▼ 3.96%
    Market cap $116.70MP/E —
    $2.32$5.46
  • GNLX
    Genelux Corporation Common Stock
    $2.42
    ▼ 2.42%
    Market cap $121.07MP/E —
    $2.29$8.54
  • CPIX
    Cumberland Pharmaceuticals Inc. Common Stock
    $7.18
    ▼ 4.77%
    Market cap $115.07MP/E —
    $1.85$9.28
  • CUE
    Cue Biopharma Inc. Common Stock
    $16.71
    ▼ 10.50%
    Market cap $113.45MP/E —
    $4.97$45.5

P/E shows — for peers not currently carrying a live signal of their own.

See the full, filterable feed with live charts on the MarketWall dashboard.

We use analytics to understand how market-wall is used. No personal data is sold.